Skip to content
DraconiticResearch
Search Sources API
210,418 studies31 sourcesUpdated 45 min ago

Oncology

5,311 studies490 in 7 days2,547 in 30 days

Filters
Type
Date
Clear

Latest

5,311 studies

  1. REDD1 in Clear Cell Renal Cell Carcinoma: Linking Stress Adaptation, Proteostasis and Therapeutic Resistance
    Sruthi Sureshkumar, Claudia M. Espitia, Fangchao Bi +6
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  2. Evaluation of the Diagnostic and Prognostic Potential, and Correlation with the Tumor Immune Microenvironment of a Six-miRNA Signature Associated with Platinum Sensitivity in Patients with Early-Stage Non-Small-Cell Lung Cancer
    Maria Mortoglou, Chara Papadaki, Aristeidis E. Boukouris +8
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  3. Liquid Biopsy in Hepatobiliary and Pancreatic Malignancies: Current Evidence and Implications for Surgical Practice
    Silvio Caringi, Antonella Delvecchio, Annachiara Casella +7
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  4. Feasibility Is Not Benefit: Resectable, Irradiable, or Biologically Selected? A Critical Review of the Unresolved Local-Platform Question in Stage III/N2 NSCLC
    Panteleimonas Skarlos, Ioannis Georgakopoulos, Andromachi Kougioumtzopoulou +6
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. Qualitative Dynamic Contrast-Enhanced MRI Time–Intensity Curve Analysis for Differentiating Non-Progressive Treatment-Related Changes from Tumor Progression After Stereotactic Radiotherapy for Brain Metastases
    Andrea Romano, Giulia Moltoni, Anna Maria Ascolese +8
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  6. Molecular Biomarker Testing in Kidney Cancer: Integrating Diagnosis, Prediction, and Emerging Renal Tumor Entities
    Busra Yaprak Bayrak, Elif Ozsagir, Nazif Alperen Yıldırım +6
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  7. Parenchyma-Sparing Strategy in Central Non-Small Cell Lung Cancer: An Institutional Experience on Surgical Selection, Complications, and Survival
    Cornel Florentin Savu, Andrei Cristian Bobocea, Amir-Andrei Sabha +4
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  8. Liquid Biopsy-Guided Surgical Decision-Making in Oligometastatic Non-Small Cell Lung Cancer: Toward Dynamic Risk Stratification in the Multidisciplinary Era
    Dimitrios E. Magouliotis, Vasiliki Androutsopoulou, Prokopis-Andreas Zotos +4
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  9. Machine Learning-Guided Virtual Screening Identifies a Novel MELK-Targeted Antiproliferative Lead Compound with G2/M Arrest Activity in Triple-Negative Breast Cancer and Lung Adenocarcinoma Cells
    Wanxin Cao, Bin Jiang, Xiangyin Chi +9
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  10. Liver Transplantation for Fibrolamellar Carcinoma: National Registry Analysis and Reported Outcomes
    Piyush Gupta, Dimitrios Moris, Caitlin Mea +5
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  11. Sentinel Node Navigation Surgery in Gastric Cancer: A Systematic Review of Diagnostic Test Accuracy and Clinical Outcomes
    Jonathan W. Kim, Helen D. Kim, Elliott Lee +1
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  12. Molecular Diagnosis of Melanocytic Neoplasia: Updates and Challenges
    Jaclyn M. Plotzke, Grace Wang, Scott C. Bresler +1
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  13. Early Local Tumour Control and Feasibility of Intratumoral P-32 Microparticle Implantation in Patients with Locally Advanced Pancreatic Cancer: A Prospective Single-Center Observational Cohort Study
    Athanasios Kontos, Ioannis Riris, Dimitrios Kypraios +3
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  14. Immunoscore and Post-Neoadjuvant Pathological Features in Microsatellite-Stable Locally Advanced Gastric Cancer: A Retrospective Cohort Study
    Özlem Kutlu, Gürkan Gül, Simge Baran +4
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  15. Reprogramming the Melanoma Tumor Microenvironment: From Cellular Crosstalk to Cellular Immunotherapy
    Enar Jumaniyazova, Elena Gantsova, Genrikh Kazarian +2
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  16. Personalized Prediction of Cutaneous Melanoma Risk Based on Polymorphism of the Genes Related to Skin Aging, Phenotypic Characteristics, and Sun Exposure in Lithuania
    Grinvydas Butrimas, Lukas Šemeklis, Renata Paukštaitienė +4
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  17. Is HER2-Low Breast Cancer a Distinct Prognostic Entity? Real-World Survival Outcomes from a Cohort in Colombia
    Edgar Fabián Manrique-Hernández, Maricel Licht-Ardila, Johan Danilo Torres Rosas +7
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  18. Advances in Interventional Oncology for Hepatocellular Carcinoma
    Sameer Gadani, Edwin Chou, Jirapa Chansangrat +2
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  19. BCIW-Net: Boundary-Conditioned Adaptive CT Windowing for Hepatocellular Carcinoma Segmentation
    Tripti Singh, Julia Rebecca Kampel, Farhan Akram +7
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  20. Ki-67 Proliferation Index Improves the Prognostic Stratification Accuracy of International Staging System in Newly Diagnosed Multiple Myeloma
    Xiaoqi Qin, Jingliang Zhao, Qirui Bai +5
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  21. An Exploratory Study of ABT-806, a Tumor-Specific Anti-EGFR Antibody, in Subjects with Recurrent or Metastatic Head and Neck and Other Squamous Cell Carcinomas
    Hui K. Gan, Sagun Parakh, Malaka Ameratunga +10
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  22. Clinical Characteristics, Progression of Disease Within 24 Months (POD24), and Real-World Outcomes of Follicular Lymphoma in Saudi Arabia: A Two-Centre Retrospective Analysis
    Mubarak Al-Mansour, Abdulrahman Salah Alharbi, Hadi Abdulhadi Sirdar +6
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  23. Retrospective Analysis of Efficacy and Toxicity of Low-Dose Weekly Cisplatin Concurrently with Radiotherapy for p16-Positive Oropharyngeal Squamous Cell Carcinoma
    Nitin Niranjan, Zulfiquer Otty, Abhishek Joshi +13
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  24. Head-to-Head Comparison Between [18F]FDG and [68Ga]Ga-Pentixafor PET/CT in Multiple Myeloma: A Systematic Review and Meta-Analysis
    Domenico Albano, Slavko Tasevski, Marco Rapa +2
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  25. Circulating Tumor DNA in Resected Colorectal Liver Metastases: From Minimal Residual Disease Detection to Treatment Guidance—A Systematic Review
    Melina Yerolatsite, Nanteznta Torounidou, Loizos Hadjigeorgiou +5
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC